Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Triflusal With Aspirin in the Secondary Prevention of Atherothrombotic Events

NCT02616497 is registered in ClinicalTrials.gov with University of Ioannina as lead sponsor.

NCT NCT02616497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02616497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Triflusal With Aspirin in the Secondary Prevention of Atherothrombotic Events
Lead sponsor
University of Ioannina
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2015
Completion date
March 28, 2018
Enrollment
1,220 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherothrombosis